Sorroza-Martínez, K.; González-Sánchez, I.; Villamil-Ramos, R.; Cerbón, M.; Guerrero-Álvarez, J.A.; Coronel-Cruz, C.; Rivera, E.; González-Méndez, I.
Using Poly(amidoamine) PAMAM-βCD Dendrimer for Controlled and Prolonged Delivery of Doxorubicin as Alternative System for Cancer Treatment. Pharmaceutics 2024, 16, 1509.
https://doi.org/10.3390/pharmaceutics16121509
AMA Style
Sorroza-Martínez K, González-Sánchez I, Villamil-Ramos R, Cerbón M, Guerrero-Álvarez JA, Coronel-Cruz C, Rivera E, González-Méndez I.
Using Poly(amidoamine) PAMAM-βCD Dendrimer for Controlled and Prolonged Delivery of Doxorubicin as Alternative System for Cancer Treatment. Pharmaceutics. 2024; 16(12):1509.
https://doi.org/10.3390/pharmaceutics16121509
Chicago/Turabian Style
Sorroza-Martínez, Kendra, Ignacio González-Sánchez, Raúl Villamil-Ramos, Marco Cerbón, Jorge Antonio Guerrero-Álvarez, Cristina Coronel-Cruz, Ernesto Rivera, and Israel González-Méndez.
2024. "Using Poly(amidoamine) PAMAM-βCD Dendrimer for Controlled and Prolonged Delivery of Doxorubicin as Alternative System for Cancer Treatment" Pharmaceutics 16, no. 12: 1509.
https://doi.org/10.3390/pharmaceutics16121509
APA Style
Sorroza-Martínez, K., González-Sánchez, I., Villamil-Ramos, R., Cerbón, M., Guerrero-Álvarez, J. A., Coronel-Cruz, C., Rivera, E., & González-Méndez, I.
(2024). Using Poly(amidoamine) PAMAM-βCD Dendrimer for Controlled and Prolonged Delivery of Doxorubicin as Alternative System for Cancer Treatment. Pharmaceutics, 16(12), 1509.
https://doi.org/10.3390/pharmaceutics16121509